Antibody informatics for drug discovery

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1844, Issue 11, 2014, Pages 2002-2015

  Shirai, Hiroki ^a   Prades, Catherine ^b   Vita, Randi ^c   Marcatili, Paolo ^d   Popovic, Bojana ^e   Xu, Jianqing ^e   Overington, John P ^f   Hirayama, Kazunori ^a   Soga, Shinji ^a   Tsunoyama, Kazuhisa ^a   Clark, Dominic ^f   Lefranc, Marie Paule ^g   Ikeda, Kazuyoshi ^f  

^a ASTELLAS PHARMA INC   (Japan)

^b SANOFI   (France)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e MEDIMMUNE   (United States)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^g CNRS and University Montpellier II   (France)

Author keywords

Antibody database; Antibody informatics; Antibody modeling; Antibody numbering; Drug discovery

Indexed keywords

ANTIBODY;

COMPUTER MODEL; DRUG BINDING; DRUG DATABASE; DRUG DEVELOPMENT; DRUG STRUCTURE; REVIEW; STRUCTURAL BIOINFORMATICS;

EID: 84907891695     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2014.07.006     Document Type: Review

References (120)

1. http://www.ebi.ac.uk/industry
2. X. Wang, T.K. Das, S.K. Singh, and S. Kumar Potential aggregation prone regions in biotherapeutics: a survey of commercial monoclonal antibodies MAbs 1 2009 254 267
3. N. Chennamsetty, V. Voynov, V. Kayser, B. Helk, and B.L. Trout Design of therapeutic proteins with enhanced stability Proc. Natl. Acad. Sci. U. S. A. 106 2009 11937 11942
4. P.R. Hinton, M.G. Johlfs, J.M. Xiong, K. Hanestad, K.C. Ong, C. Bullock, S. Keller, M.T. Tang, J.Y. Tso, M. Vasquez, and N. Tsurushita Engineered human IgG antibodies with longer serum half-lives in primates J. Biol. Chem. 279 2004 6213 6216
5. A. Datta-Mannan, D.R. Witcher, Y. Tang, J. Watkins, W. Jiang, and V.J. Wroblewski Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates Drug Metab. Dispos. 35 2007 86 94
6. D. Kuroda, H. Shirai, M.P. Jacobson, and H. Nakamura Computer-aided antibody design Protein Eng. Des. Sel. 25 2012 507 521
7. P. Marcatili, A. Rosi, and A. Tramontano PIGS: automatic prediction of antibody structures Bioinformatics 24 2008 1953 1954
8. D. Kuroda, H. Shirai, M. Kobori, and H. Nakamura Structural classification of CDR-H3 revisited: a lesson in antibody modeling Proteins 73 2008 608 620
9. X. Yang, W. Xu, S. Dukleska, S. Benchaar, S. Mengisen, V. Antochshuk, J. Cheung, L. Mann, Z. Babadjanova, J. Rowand, R. Gunawan, A. McCampbell, M. Beaumont, D. Meininger, D. Richardson, and A. Ambrogelly Developability studies before initiation of process development: improving manufacturability of monoclonal antibodies MAbs 5 2013 787 794
10. V. Jawa, L.P. Cousens, M. Awwad, E. Wakshull, H. Kropshofer, and A.S. De Groot T-cell dependent immunogenicity of protein therapeutics: preclinical assessment and mitigation Clin. Immunol. 149 2013 534 555
11. S. Paul, R.V. Kolla, J. Sidney, D. Weiskopf, W. Fleri, Y. Kim, B. Peters, and A. Sette Evaluating the immunogenicity of protein drugs by applying in vitro MHC binding data and the immune epitope database and analysis resource Clin. Dev. Immunol. 2013 2013 467852
12. S.T. Reddy, X. Ge, A.E. Miklos, R.A. Hughes, S.H. Kang, K.H. Hoi, C. Chrysostomou, S.P. Hunicke-Smith, B.L. Iverson, P.W. Tucker, A.D. Ellington, and G. Georgiou Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells Nat. Biotechnol. 28 2010 965 969
13. X. Wu, T. Zhou, J. Zhu, B. Zhang, I. Georgiev, C. Wang, X. Chen, N.S. Longo, M. Louder, K. McKee, S. O'Dell, S. Perfetto, S.D. Schmidt, W. Shi, L. Wu, Y. Yang, Z.Y. Yang, Z. Yang, Z. Zhang, M. Bonsignori, J.A. Crump, S.H. Kapiga, N.E. Sam, B.F. Haynes, M. Simek, D.R. Burton, W.C. Koff, N.A. Doria-Rose, M. Connors, J.C. Mullikin, G.J. Nabel, M. Roederer, L. Shapiro, P.D. Kwong, and J.R. Mascola Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing Science 333 2011 1593 1602
14. J.C. Almagro, and J. Fransson Humanization of antibodies Front. Biosci. 13 2008 1619 1633
15. A.E. Miklos, C. Kluwe, B.S. Der, S. Pai, A. Sircar, R.A. Hughes, M. Berrondo, J. Xu, V. Codrea, P.E. Buckley, A.M. Calm, H.S. Welsh, C.R. Warner, M.A. Zacharko, J.P. Carney, J.J. Gray, G. Georgiou, B. Kuhlman, and A.D. Ellington Structure-based design of supercharged, highly thermoresistant antibodies Chem. Biol. 19 2012 449 455
16. J. Xu, D. Tack, R.A. Hughes, A.D. Ellington, and J.J. Gray Structure-based non-canonical amino acid design to covalently crosslink an antibody-antigen complex J. Struct. Biol. 185 2014 215 222
17. M. Kiyoshi, J.M. Caaveiro, E. Miura, S. Nagatoishi, M. Nakakido, S. Soga, H. Shirai, S. Kawabata, and K. Tsumoto Affinity improvement of a therapeutic antibody by structure-based computational design: generation of electrostatic interactions in the transition state stabilizes the antibody-antigen complex PLoS One 9 2014 e87099
18. http://www.chemcomp.com/index.htm
19. http://accelrys.com/
20. A. Fukunaga, and K. Tsumoto Improving the affinity of an antibody for its antigen via long-range electrostatic interactions Protein Eng. Des. Sel. 26 2013 773 780
21. K. Tharakaraman, L.N. Robinson, A. Hatas, Y.L. Chen, L. Siyue, S. Raguram, V. Sasisekharan, G.N. Wogan, and R. Sasisekharan Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency Proc. Natl. Acad. Sci. U. S. A. 110 2013 E1555 E1564
22. T.T. Wu, and E.A. Kabat An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity J. Exp. Med. 132 1970 211 250
23. C. Chothia, and A.M. Lesk Canonical structures for the hypervariable regions of immunoglobulins J. Mol. Biol. 196 1987 901 917
24. C. Chothia, A.M. Lesk, A. Tramontano, M. Levitt, S.J. Smith-Gill, G. Air, S. Sheriff, E.A. Padlan, D. Davies, and W.R. Tulip Conformations of immunoglobulin hypervariable regions Nature 342 1989 877 883
25. B. North, A. Lehmann, and R.L. Dunbrack A new clustering of antibody CDR loop conformations J. Mol. Biol. 406 2011 228 256
26. B. Al-Lazikani, A.M. Lesk, and C. Chothia Standard conformations for the canonical structures of immunoglobulins J. Mol. Biol. 273 1997 927 948
27. A. Chailyan, P. Marcatili, D. Cirillo, and A. Tramontano Structural repertoire of immunoglobulin lambda light chains Proteins 79 2011 1513 1524
28. D. Kuroda, H. Shirai, M. Kobori, and H. Nakamura Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface Proteins 75 2009 139 146
29. A.C. Martin, and J.M. Thornton Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies J. Mol. Biol. 263 1996 800 815
30. P. Verdino, D.A. Witherden, K. Podshivalova, S.E. Rieder, W.L. Havran, and I.A. Wilson cDNA sequence and Fab crystal structure of HL4E10, a hamster IgG lambda light chain antibody stimulatory for gammadelta T cells PLoS One 6 2011 e19828
31. A. Sircar, K.A. Sanni, J. Shi, and J.J. Gray Analysis and modeling of the variable region of camelid single-domain antibodies J. Immunol. 186 2011 6357 6367
32. O. Lopez, C. Perez, and D. Wylie A single VH family and long CDR3s are the targets for hypermutation in bovine immunoglobulin heavy chains Immunol. Rev. 162 1998 55 66
33. F. Wang, D.C. Ekiert, I. Ahmad, W. Yu, Y. Zhang, O. Bazirgan, A. Torkamani, T. Raudsepp, W. Mwangi, M.F. Criscitiello, I.A. Wilson, P.G. Schultz, and V.V. Smider Reshaping antibody diversity Cell 153 2013 1379 1393
34. N.R. Whitelegg, and A.R. Rees WAM: an improved algorithm for modelling antibodies on the WEB Protein Eng. 13 2000 819 824
35. L. Holm, L. Laaksonen, M. Kaartinen, T.T. Teeri, and J.K. Knowles Molecular modelling study of antigen binding to oxazolone-specific antibodies: the Ox1 idiotypic IgG and its mature variant with increased affinity to 2-phenyloxazolone Protein Eng. 3 1990 403 409
36. A.C. Martin, J.C. Cheetham, and A.R. Rees Modeling antibody hypervariable loops: a combined algorithm Proc. Natl. Acad. Sci. U. S. A. 86 1989 9268 9272
37. A. Sircar, E.T. Kim, and J.J. Gray RosettaAntibody: antibody variable region homology modeling server Nucleic Acids Res. 37 2009 W474 W479
38. B.D. Weitzner, D. Kuroda, N. Marze, J. Xu, and J.J. Gray Blind prediction performance of RosettaAntibody 3.0: grafting, relaxation, kinematic loop modeling, and full CDR optimization Proteins 82 2014 1611 1623
39. K.W. Kaufmann, G.H. Lemmon, S.L. Deluca, J.H. Sheehan, and J. Meiler Practically useful: what the Rosetta protein modeling suite can do for you Biochemistry 49 2010 2987 2998
40. A. Leaver-Fay, M. Tyka, S.M. Lewis, O.F. Lange, J. Thompson, R. Jacak, K. Kaufman, P.D. Renfrew, C.A. Smith, W. Sheffler, I.W. Davis, S. Cooper, A. Treuille, D.J. Mandell, F. Richter, Y.E. Ban, S.J. Fleishman, J.E. Corn, D.E. Kim, S. Lyskov, M. Berrondo, S. Mentzer, Z. Popovic, J.J. Havranek, J. Karanicolas, R. Das, J. Meiler, T. Kortemme, J.J. Gray, B. Kuhlman, D. Baker, and P. Bradley ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules Methods Enzymol. 487 2011 545 574
41. A.A. Canutescu, and R.L. Dunbrack Jr. Cyclic coordinate descent: a robotics algorithm for protein loop closure Protein Sci. 12 2003 963 972
42. D.J. Mandell, E.A. Coutsias, and T. Kortemme Sub-angstrom accuracy in protein loop reconstruction by robotics-inspired conformational sampling Nat. Methods 6 2009 551 552
43. Y. Choi, and C.M. Deane Predicting antibody complementarity determining region structures without classification Mol. Biosyst. 7 2011 3327 3334
44. P.T.; C.A. Janeway Jr.; and M. Walport Immunobiology: The Immune System in Health and Disease 5th edition 2001 Garland Science New York
45. V. Morea, A. Tramontano, M. Rustici, C. Chothia, and A.M. Lesk Conformations of the third hypervariable region in the VH domain of immunoglobulins J. Mol. Biol. 275 1998 269 294
46. H. Shirai, A. Kidera, and H. Nakamura Structural classification of CDR-H3 in antibodies FEBS Lett. 399 1996 1 8
47. H. Shirai, A. Kidera, and H. Nakamura H3-rules: identification of CDR-H3 structures in antibodies FEBS Lett. 455 1999 188 197
48. S.T. Kim, H. Shirai, N. Nakajima, J. Higo, and H. Nakamura Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue Proteins 37 1999 683 696
49. I. Sela-Culang, S. Alon, and Y. Ofran A systematic comparison of free and bound antibodies reveals binding-related conformational changes J. Immunol. 189 2012 4890 4899
50. K. Zhu, D.L. Pincus, S. Zhao, and R.A. Friesner Long loop prediction using the protein local optimization program Proteins 65 2006 438 452
51. H. Shirai High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations The Annual Meeting of the Antibody Society, Huntington Beach, CA December 8-12, 2013
52. K.R. Abhinandan, and A.C. Martin Analysis and prediction of VH/VL packing in antibodies Protein Eng. Des. Sel. 23 2010 689 697
53. A. Chailyan, P. Marcatili, and A. Tramontano The association of heavy and light chain variable domains in antibodies: implications for antigen specificity FEBS J. 278 2011 2858 2866
54. J. Dunbar, A. Fuchs, J. Shi, and C.M. Deane ABangle: characterising the VH-VL orientation in antibodies Protein Eng. Des. Sel. 26 2013 611 620
55. X.M. Fernandez-Suarez, D.J. Rigden, and M.Y. Galperin The 2014 Nucleic Acids Research Database Issue and an updated NAR online Molecular Biology Database Collection Nucleic Acids Res. 42 2014 D1 D6
56. R. Vita, L. Zarebski, J.A. Greenbaum, H. Emami, I. Hoof, N. Salimi, R. Damle, A. Sette, and B. Peters The immune epitope database 2.0 Nucleic Acids Res. 38 2010 D854 D862
57. A. Chailyan, A. Tramontano, and P. Marcatili A database of immunoglobulins with integrated tools: DIGIT Nucleic Acids Res. 40 2012 D1230 D1234
58. P. Marcatili, F. Ghiotto, C. Tenca, A. Chailyan, A.N. Mazzarello, X.J. Yan, M. Colombo, E. Albesiano, D. Bagnara, G. Cutrona, F. Morabito, S. Bruno, M. Ferrarini, N. Chiorazzi, A. Tramontano, and F. Fais Igs expressed by chronic lymphocytic leukemia B cells show limited binding-site structure variability J. Immunol. 190 2013 5771 5778
59. F. Ghiotto, P. Marcatili, C. Tenca, M.G. Calevo, X.J. Yan, E. Albesiano, D. Bagnara, M. Colombo, G. Cutrona, C.C. Chu, F. Morabito, S. Bruno, M. Ferrarini, A. Tramontano, F. Fais, and N. Chiorazzi Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cells Mol. Med. 17 2011 1188 1195
60. S. Zibellini, D. Capello, F. Forconi, P. Marcatili, D. Rossi, S. Rattotti, S. Franceschetti, E. Sozzi, E. Cencini, R. Marasca, L. Baldini, A. Tucci, F. Bertoni, F. Passamonti, E. Orlandi, M. Varettoni, M. Merli, S. Rizzi, V. Gattei, A. Tramontano, M. Paulli, G. Gaidano, and L. Arcaini Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma Haematologica 95 2010 1792 1796
61. A. Gaulton, L.J. Bellis, A.P. Bento, J. Chambers, M. Davies, A. Hersey, Y. Light, S. Mcglinchey, D. Michalovich, B. Al-Lazikani, and J.P. Overington ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res. 40 2012 D1100 D1107
62. A.P. Bento, A. Gaulton, A. Hersey, L.J. Bellis, J. Chambers, M. Davies, F.A. Kruger, Y. Light, L. Mak, S. McGlinchey, M. Nowotka, G. Papadatos, R. Santos, and J.P. Overington The ChEMBL bioactivity database: an update Nucleic Acids Res. 42 2014 D1083 D1090
63. L.J. Bellis, R. Akhtar, B. Al-Lazikani, F. Atkinson, A.P. Bento, J. Chambers, M. Davies, A. Gaulton, A. Hersey, K. Ikeda, F.A. Krüger, Y. Light, S. McGlinchey, R. Santos, B. Stauch, and J.P. Overington Collation and data-mining of literature bioactivity data for drug discovery Biochem. Soc. Trans. 39 2011 1365 1370
64. Q. Li, T. Cheng, Y. Wang, and S.H. Bryant PubChem as a public resource for drug discovery Drug Discov. Today 15 2010 1052 1057
65. C. Knox, V. Law, T. Jewison, P. Liu, S. Ly, A. Frolkis, A. Pon, K. Banco, C. Mak, V. Neveu, Y. Djoumbou, R. Eisner, A.C. Guo, and D.S. Wishart DrugBank 3.0: a comprehensive resource for 'omics' research on drugs Nucleic Acids Res. 39 2011 D1035 D1041
66. J.P. Overington, B. Al-Lazikani, and A.L. Hopkins How many drug targets are there? Nat. Rev. Drug Discov. 5 2006 993 996
67. M. Rask-Andersen, M.S. Almen, and H.B. Schioth Trends in the exploitation of novel drug targets Nat. Rev. Drug Discov. 10 2011 579 590
68. D. Gardner, H. Akil, G.A. Ascoli, D.M. Bowden, W. Bug, D.E. Donohue, D.H. Goldberg, B. Grafstein, J.S. Grethe, A. Gupta, M. Halavi, D.N. Kennedy, L. Marenco, M.E. Martone, P.L. Miller, H.M. Muller, A. Robert, G.M. Shepherd, P.W. Sternberg, D.C. Van Essen, and R.W. Williams The neuroscience information framework: a data and knowledge environment for neuroscience Neuroinformatics 6 2008 149 160
69. http://antibodyregistry.org
70. S.M. Major, S. Nishizuka, D. Morita, R. Rowland, M. Sunshine, U. Shankavaram, F. Washburn, D. Asin, H. Kouros-Mehr, D. Kane, and J.N. Weinstein AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies BMC Bioinformatics 7 2006 192
71. http://www.antibodypedia.com
72. https://www.phe-culturecollections.org.uk/products/celllines/hybridoma/search.jsp
73. http://www.gallartinternet.com/mai/index.htm
74. http://www.imgt.org
75. M.-P. Lefranc, V. Giudicelli, C. Ginestoux, J. Jabado-Michaloud, G. Folch, F. Bellahcene, Y. Wu, E. Gemrot, X. Brochet, J. Lane, L. Regnier, F. Ehrenmann, G. Lefranc, and P. Duroux IMGT, the international ImMunoGeneTics information system Nucleic Acids Res. 37 2009 D1006 D1012
76. M.-P. Lefranc Immunoglobulin (IG) and T cell receptor genes (TR): IMGT® and the birth and rise of immunoinformatics Front. Immunol. 5 2014 22
77. V. Giudicelli, and M.-P. Lefranc IMGT-ONTOLOGY O.W.W. Dubitzky, K.-H. Cho, H. Yokota, Encyclopedia of Systems Biology 2013 Springer Science + Business Media, LLC012 New York 964 972
78. M.-P. Lefranc Antibody informatics: IMGT®, the international ImMunoGeneTics information system® Microbiol. Spectr. 2 2 2014 (AID-0001)
79. E.A. Kabat, T.T. Wu, M. Reid-Miller, H. Perry, and K. Gottesman Sequences of Proteins of Immunological Interest 4th ed. 1987 U. S. Govt. Bethesda, MD Printing Off. No. 165-492
80. E.A. Kabat, T.T. Wu, H. Perry, K. Gottesman, and C. Foeller Sequences of Proteins of Immunological Interest 5th ed. 1991 NIH Publication Bethesda, MD No. 91-3242
81. K.R. Abhinandan, and A.C. Martin Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains Mol. Immunol. 45 2008 3832 3839
82. A. Honegger, and A. Plückthun Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool J. Mol. Biol. 309 2001 657 670
83. M.-P. Lefranc Unique database numbering system for immunogenetic analysis Immunol. Today 18 1997 509
84. http://www.imgt.org/IMGTrepertoire/2D-3Dstruct/2D-representations/mouse/IG/E5.2Fv/ighVD-J-E5-2Fv.html
85. M.-P. Lefranc The IMGT unique numbering for Immunoglobulins, T cell receptors and Ig-like domains The Immunologist 7 1999 132 136
86. M.-P. Lefranc, C. Pommie, M. Ruiz, V. Giudicelli, E. Foulquier, L. Truong, V. Thouvenin-Contet, and G. Lefranc IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains Dev. Comp. Immunol. 27 2003 55 77
87. Y. Satow, G.H. Cohen, E.A. Padlan, and D.R. Davies Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 Å J. Mol. Biol. 190 1986 593 604
88. http://www.imgt.org/IMGTScientificChart/Numbering/IMGTcorrespondence.html
89. M.-P. Lefranc Antibody nomenclature: from IMGT-ONTOLOGY to INN definition MAbs 3 2011 1 2
90. M.-P. Lefranc, C. Pommie, Q. Kaas, E. Duprat, N. Bosc, D. Guiraudou, C. Jean, M. Ruiz, I. Da Piedade, M. Rouard, E. Foulquier, V. Thouvenin, and G. Lefranc IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains Dev. Comp. Immunol. 29 2005 185 203
91. M.-P. Lefranc IMGT unique numbering for the variable (V), constant (C), and groove (G) domains of IG, TR, MH, IgSF, and MhSF Cold Spring Harb. Protoc. 2011 2011 633 642
92. M.-P. Lefranc, and G. Lefranc The Immunoglobulin FactsBook 2001 Academic Press London
93. M.-P. Lefranc, and G. Lefranc The T Cell Receptor FactsBook 2001 Academic Press London
94. V. Giudicelli, and M.-P. Lefranc Ontology for immunogenetics: the IMGT-ONTOLOGY Bioinformatics 15 1999 1047 1054
95. V. Giudicelli, and M.-P. Lefranc IMGT-ONTOLOGY 2012 Front. Genet. 3 2012 79
96. M.-P. Lefranc From IMGT-ONTOLOGY IDENTIFICATION axiom to IMGT standardized keywords: for immunoglobulins (IG), T cell receptors (TR), and conventional genes Cold Spring Harb. Protoc. 2011 2011 604 613
97. M.-P. Lefranc From IMGT-ONTOLOGY DESCRIPTION axiom to IMGT standardized labels: for immunoglobulin (IG) and T cell receptor (TR) sequences and structures Cold Spring Harb. Protoc. 2011 2011 614 626
98. M.-P. Lefranc From IMGT-ONTOLOGY CLASSIFICATION axiom to IMGT standardized gene and allele nomenclature: for immunoglobulins (IG) and T cell receptors (TR) Cold Spring Harb. Protoc. 2011 2011 627 632
99. M.-P. Lefranc IMGT Collier de Perles for the variable (V), constant (C), and groove (G) domains of IG, TR, MH, IgSF, and MhSF Cold Spring Harb. Protoc. 2011 2011 643 651
100. M. Ruiz, and M.-P. Lefranc IMGT gene identification and Colliers de Perles of human immunoglobulins with known 3D structures Immunogenetics 53 2002 857 883
101. E. Alamyar, V. Giudicelli, L. Shuo, P. Duroux, and M.-P. Lefranc IMGT/HighV-QUEST: the IMGT® web portal for immunoglobulin (IG) or antibody and T cell receptor (TR) analysis from NGS high throughput and deep sequencing Immunome Res. 8 1 2012 26
102. S. Li, M.-P. Lefranc, J.J. Miles, E. Alamyar, V. Giudicelli, P. Duroux, J.D. Freeman, V.D. Corbin, J.P. Scheerlinck, M.A. Frohman, P.U. Cameron, M. Plebanski, B. Loveland, S.R. Burrows, A.T. Papenfuss, and E.J. Gowans IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling Nat. Commun. 4 2013 2333
103. V. Giudicelli, D. Chaume, and M.-P. Lefranc IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis Nucleic Acids Res. 32 2004 W435 W440
104. E. Alamyar, P. Duroux, M.-P. Lefranc, and V. Giudicelli IMGT((R)) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS Methods Mol. Biol. 882 2012 569 604
105. M. Yousfi Monod, V. Giudicelli, D. Chaume, and M.-P. Lefranc IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J junctions Bioinformatics 20 Suppl. 1 2004 i379 i385
106. V. Giudicelli, and M.-P. Lefranc IMGT/JunctionAnalysis: IMGT standardized analysis of the V-J and V-D-J junctions of the rearranged immunoglobulins (IG) and T cell receptors (TR) Cold Spring Harb. Protoc. 2011 2011 716 725
107. F. Ehrenmann, V. Giudicelli, P. Duroux, and M.-P. Lefranc IMGT/Collier de Perles: IMGT standardized representation of domains (IG, TR, and IgSF variable and constant domains, MH and MhSF groove domains) Cold Spring Harb. Protoc. 2011 2011 726 736
108. F. Ehrenmann, and M.-P. Lefranc IMGT/DomainGapAlign: IMGT standardized analysis of amino acid sequences of variable, constant, and groove domains (IG, TR, MH, IgSF, MhSF) Cold Spring Harb. Protoc. 2011 2011 737 749
109. F. Ehrenmann, and M.-P. Lefranc IMGT/DomainGapAlign: the IMGT® tool for the analysis of IG, TR, MH, IgSF, and MhSF domain amino acid polymorphism Methods Mol. Biol. 882 2012 605 633
110. F. Ehrenmann, Q. Kaas, and M.-P. Lefranc IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF Nucleic Acids Res. 38 2010 D301 D307
111. F. Ehrenmann, and M.-P. Lefranc IMGT/3Dstructure-DB: querying the IMGT database for 3D structures in immunology and immunoinformatics (IG or antibodies, TR, MH, RPI, and FPIA) Cold Spring Harb. Protoc. 2011 2011 750 761
112. C. Pommie, S. Levadoux, R. Sabatier, G. Lefranc, and M.-P. Lefranc IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties J. Mol. Recognit. 17 2004 17 32
113. V. Giudicelli, P. Duroux, C. Ginestoux, G. Folch, J. Jabado-Michaloud, D. Chaume, and M.-P. Lefranc IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences Nucleic Acids Res. 34 2006 D781 D784
114. V. Giudicelli, D. Chaume, and M.-P. Lefranc IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes Nucleic Acids Res. 33 2005 D256 D261
115. C. Poiron, Y. Wu, C. Ginestoux, F. Ehrenmann, P. Duroux, and M.-P. Lefranc IMGT/mAb-DB: the IMGT® database for therapeutic monoclonal antibodies 11èmes Journées Ouvertes de Biologie, Informatique et Mathématiques (JOBIM], Montpellier, 7-9 September 2010 2010
116. M.-P. Lefranc, and G. Lefranc Human Gm, Km, and Am allotypes and their molecular characterization: a remarkable demonstration of polymorphism Methods Mol. Biol. 882 2012 635 680
117. C. Dechavanne, F. Guillonneau, G. Chiappetta, L. Sago, P. Levy, V. Salnot, E. Guitard, F. Ehrenmann, C. Broussard, P. Chafey, A. Le Port, J. Vinh, P. Mayeux, J.M. Dugoujon, M.-P. Lefranc, and F. Migot-Nabias Mass spectrometry detection of G3m and IGHG3 alleles and follow-up of differential mother and neonate IgG3 PLoS One 7 2012 e46097
118. M.-P. Lefranc Antibody databases and tools: the IMGT® experience Zhiqiang An, Therapeutic Monoclonal Antibodies: From Bench to Clinic 2009 John Wiley & Sons, Inc. 91 114 (chap. 4)
119. F. Ehrenmann, P. Duroux, V. Giudicelli, and M.-P. Lefranc Standardized sequence and structure analysis of antibody using IMGT® R. Kontermann, S. Dübel, Antibody Engineering vol. 2 2010 Springer-Verlab Berlin Heidelberg 11 31 (chap. 2)
120. M.-P. Lefranc, F. Ehrenmann, C. Ginestoux, P. Duroux, and V. Giudicelli Use of IMGT® databases and tools for antibody engineering and humanization P. Chames, Antibody Engineering Methods Mol Biol 907 2012 Humana Press, Springer New York, USA 3 37 (chap 1)